High‐Level Fluoroquinolone Resistance in Pseudomonas aeruginosa Due to Interplay of the MexAB‐OprM Efflux Pump and the DNA Gyrase Mutation
暂无分享,去创建一个
[1] L. Mandell,et al. Fluoroquinolone Resistance in Clinical Isolates ofStreptococcus pneumoniae: Contributions of Type II Topoisomerase Mutations and Efflux to Levels of Resistance , 2000, Antimicrobial Agents and Chemotherapy.
[2] H. Yoneyama,et al. Assignment of the Substrate-Selective Subunits of the MexEF-OprN Multidrug Efflux Pump of Pseudomonas aeruginosa , 2000, Antimicrobial Agents and Chemotherapy.
[3] H. Yoneyama,et al. nalB-type mutations causing the overexpression of the MexAB-OprM efflux pump are located in the mexR gene of the Pseudomonas aeruginosa chromosome. , 1999, FEMS microbiology letters.
[4] H. Yoneyama,et al. Resistance to β-Lactam Antibiotics inPseudomonas aeruginosa Due to Interplay between the MexAB-OprM Efflux Pump and β-Lactamase , 1999, Antimicrobial Agents and Chemotherapy.
[5] H. Yoneyama,et al. Resistance to beta-lactam antibiotics in Pseudomonas aeruginosa due to interplay between the MexAB-OprM efflux pump and beta-lactamase. , 1999, Antimicrobial agents and chemotherapy.
[6] H. Yoneyama,et al. Use of Fluorescence Probes to Monitor Function of the Subunit Proteins of the MexA-MexB-OprM Drug Extrusion Machinery inPseudomonas aeruginosa * , 1997, The Journal of Biological Chemistry.
[7] H. Yoneyama,et al. The Role ofmex-Gene Products in Antibiotic Extrusion inPseudomonas aeruginosa , 1997 .
[8] H. Yoneyama,et al. The role of mex-gene products in antibiotic extrusion in Pseudomonas aeruginosa. , 1997, Biochemical and biophysical research communications.
[9] S. Banerjee,et al. Involvement of an efflux system in mediating high level of fluoroquinolone resistance in Mycobacterium smegmatis. , 1996, Biochemical and biophysical research communications.
[10] D. Heinrichs,et al. Expression of the multidrug resistance operon mexA-mexB-oprM in Pseudomonas aeruginosa: mexR encodes a regulator of operon expression , 1996, Antimicrobial agents and chemotherapy.
[11] K. Hoshino,et al. Contribution of the C-8 substituent of DU-6859a, a new potent fluoroquinolone, to its activity against DNA gyrase mutants of Pseudomonas aeruginosa , 1995, Antimicrobial agents and chemotherapy.
[12] D. Heinrichs,et al. Cloning and sequence analysis of an EnvCD homologue in Pseudomonas aeruginosa: regulation by iron and possible involvement in the secretion of the siderophore pyoverdine , 1993, Molecular microbiology.
[13] S. Mitsuhashi,et al. Some properties of subunits of DNA gyrase from Pseudomonas aeruginosa PAO1 and its nalidixic acid-resistant mutant , 1987, Journal of bacteriology.